NCT05333601

Brief Summary

The psychosocial needs of children with cancer and their families are well-documented in the literature, including the increased risk of parental posttraumatic stress, parental anxiety, and decreased family functioning. There is a critical need to provide evidence-based psychosocial care to parents of children with cancer, although many challenges exist with regard to in-person intervention delivery. eHealth interventions represent an exciting potential opportunity to address many of the barriers to in-person intervention delivery in this population, but are not yet widely utilized in pediatric psychosocial cancer care. eSCCIP is an innovative eHealth intervention for parents of children with cancer, delivered through a combination of self-guided interactive online content and telehealth follow-up with a therapist. eSCCIP aims to decrease symptoms of anxiety, distress, and posttraumatic stress while improving family functioning by delivering evidence-based therapeutic content through a flexible, easily accessible intervention tool. The four self-guided online modules feature a mix of didactic video content, novel multifamily video discussion groups featuring parents of children with cancer, and hands-on interactive activities. Preliminary Think Aloud testing has been completed and led to several rounds of design and functionality improvements. The objective of the proposed study is to establish feasibility and acceptability of eSCCIP in a diverse group of parents of children with cancer. A secondary, exploratory goal is to evaluate preliminary intervention effectiveness for key psychosocial outcomes. Specific Aim 1 is to identify strategies for increasing participant engagement and retention by conducting focus groups with a diverse sample of parents of children with cancer prior to pilot testing. Specific Aim 2 is to demonstrate the feasibility of eSCCIP through pilot testing with a diverse sample of parents of children with cancer. Specific Aim 3 is to evaluate preliminary effectiveness of eSCCIP through pilot testing with parents of children with cancer. The proposed study is an important first step in meeting a critical need for families of children with cancer and collecting data to power a randomized clinical trial to establish clinical efficacy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 19, 2022

Completed
6 months until next milestone

Results Posted

Study results publicly available

October 19, 2022

Completed
Last Updated

June 11, 2024

Status Verified

June 1, 2024

Enrollment Period

2.1 years

First QC Date

April 11, 2022

Results QC Date

May 17, 2022

Last Update Submit

June 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The eSCCIP Evaluation Questionnaire

    The eSCCIP Evaluation Questionnaire is a questionnaire designed to evaluate intervention acceptability, feasibility, and usability. Data is descriptive and examined at the item-level. Each item is scored on a 0-4 Likert scale (Not at all true - Very true). Mean score with standard deviation are reported at the item-level.

    Up to 6 weeks.

Secondary Outcomes (5)

  • Distress Thermometer

    Up to 9 weeks

  • Generalized Anxiety Disorder - 7 (GAD-7)

    Up to 9 weeks

  • SCORE-15

    Up to 9 weeks

  • PTSD Checklist for DSM-5 (PCL-5)

    Up to 9 weeks.

  • The COVID-19 Exposure and Family Impact Scales (CEFIS)

    Up to 9 weeks.

Study Arms (1)

eSCCIP

EXPERIMENTAL

The Electronic Surviving Cancer Competently Intervention Program (eSCCIP) is an innovative eHealth intervention that combines cognitive behavioral and family systems therapy to provide parents and caregivers of children with cancer (PCCC) with evidence-based coping skills and psychosocial support focused on the family unit. eSCCIP has three 30-minute, self-directed, online modules which feature a unique mix of original video content and interactive activities, supplemented by three telehealth follow-up sessions. eSCCIP aims to reduce acute distress and symptoms of post-traumatic stress while increasing positive coping self-appraisal and use of cognitive coping skills.

Behavioral: eSCCIP

Interventions

eSCCIPBEHAVIORAL

The Electronic Surviving Cancer Competently Intervention Program (eSCCIP) is an innovative eHealth intervention that combines cognitive behavioral and family systems therapy to provide parents and caregivers of children with cancer (PCCC) with evidence-based coping skills and psychosocial support focused on the family unit. eSCCIP has three 30-minute, self-directed, online modules which feature a unique mix of original video content and interactive activities, supplemented by three telehealth follow-up sessions. eSCCIP aims to reduce acute distress and symptoms of post-traumatic stress while increasing positive coping self-appraisal and use of cognitive coping skills.

eSCCIP

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be the parent or primary caregiver of a child (ages 0 - 18 years old) diagnosed with cancer.
  • Participants must be able to speak and read English.
  • Participants must have access to the internet through a computer or mobile device (e.g., smartphone, tablet).

You may not qualify if:

  • \- Potential participants are ineligible to participate if their child is not expected to live longer than six months from the time of potential recruitment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours Children's Health

Wilmington, Delaware, 19803, United States

Location

MeSH Terms

Conditions

Neoplasms

Results Point of Contact

Title
Dr. Kimberly Canter
Organization
Nemours Children's Health

Study Officials

  • Kimberly Canter, PhD

    Nemours Children's Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Single group pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Scientist

Study Record Dates

First Submitted

April 11, 2022

First Posted

April 19, 2022

Study Start

January 1, 2020

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

June 11, 2024

Results First Posted

October 19, 2022

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations